| Structure |
Chemical Name |
CAS |
MF |
 |
Rotigotine Impurity 9 |
|
|
 |
Febuxostat Impurity 73 |
|
|
 |
Vildagliptin Impurity 36 |
|
|
![9-fluoro-6,7-dihydro-5-methyl-1-oxo-8-(4-oxo-1,2,3,4-tetrahydro-1-pyridyl)-1H,5H-benzo[i,j]quinolizine-2-carboxylic acid](/CAS/20200401/GIF/130539-72-9.gif) |
9-fluoro-6,7-dihydro-5-methyl-1-oxo-8-(4-oxo-1,2,3,4-tetrahydro-1-pyridyl)-1H,5H-benzo[i,j]quinolizine-2-carboxylic acid |
130539-72-9 |
C19H17FN2O4 |
 |
Nicardipine Related CoMpound 4 |
123973-71-7 |
C25H27N3O6 |
 |
(E)-3-(4-((3-(1-(4-((1H-imidazol-1-yl)methyl)phenyl)-2-carboxyethyl)-1H-imidazol-3-ium-1-yl)methyl)phenyl)acrylate |
|
|
 |
Avibactam Impurity 04 |
|
|
 |
(3R,5S,Z)-7-(4-(4-fluorophenyl)-6-isopropyl-2-(N-methylmethylsulfonamido)pyrimidin-5-yl)-3,5-dihydroxyhept-6-enoic acid calcium(II) |
1445208-17-2 |
C22H28FN3O6S |
![(2S)-1-[(2S)-2-[[(1S)-3-Phenyl-1-[(2phenylethoxy) carbonyl]propyl]aMino]propanoyl]pyrrolidine-2-carboxylic acid](/CAS/20130318/GIF/CB52605019.gif) |
(2S)-1-[(2S)-2-[[(1S)-3-Phenyl-1-[(2phenylethoxy) carbonyl]propyl]aMino]propanoyl]pyrrolidine-2-carboxylic acid |
|
C26H31N2O5 |
 |
Exemestane Impurity 6 |
14895-71-7 |
|
 |
(2R,3R,4R,5R)-2-(4-amino-2-oxo-1,3,5-triazin-1(2H)-yl)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-3-yl acetate |
|
C10H14N4O6 |
 |
Sitafloxacin Impurity 19 |
|
|
 |
EMpagliflozin iMpurity 8 |
|
|
 |
Vortioxetine Imp.E |
508233-77-0 |
C18H22N2S |
 |
Org246653-1(RRT0.35) |
|
|
 |
Cefazoline Impurity A |
|
|
 |
2-(4-hydroxy-1-methyl-7-phenoxy-5,6,7,8-tetrahydroisoquinoline-3-carboxamido)acetic acid |
|
|
 |
monocalcium mono((3R,5S,E)-7-(4-(2-fluorophenyl)-6-isopropyl-2- (N-methylmethylsulfonamido)pyrimidin-5-yl)-3,5-dihydroxyhept-6- enoate) |
|
|
![4H-Furo[2,3-c]pyranyl Mupirocin SodiuM IMpurity](/CAS/GIF/116182-43-5.gif) |
4H-Furo[2,3-c]pyranyl Mupirocin SodiuM IMpurity |
116182-43-5 |
C26H43NaO9 |
 |
Oxiracetam Impurity I |
142274-07-5 |
C7H9NO4 |
 |
1-メチル-2-オキソシクロペンタンカルボン酸エチル |
5453-88-3 |
C9H14O3 |
 |
Nicorandil Impurity A |
|
|
 |
2-(4-butoxy-3-cyanophenyl)-4-methylthiazole-5-carboxylic acid |
1657014-33-9 |
C16H16N2O3S |
![2-[(2-AZIDOETHOXY)METHYL]-4-(2-CHLOROPHENYL)-3-ETHOXYCARBONYL-5-METHOXYCARBONYL)-6-METHYL-1,4-DIHYDROPYRIDINE](/CAS/GIF/88150-46-3.gif) |
2-[(2-AZIDOETHOXY)METHYL]-4-(2-CHLOROPHENYL)-3-ETHOXYCARBONYL-5-METHOXYCARBONYL)-6-METHYL-1,4-DIHYDROPYRIDINE |
88150-46-3 |
C20H23ClN4O5 |
 |
Peramivir Impurity 11 |
|
|
 |
Ceftriaxone IMpurit B |
|
|
![3-((3S,4R)-4-Methyl-3-(Methyl(7H-pyrrolo[2,3-d]pyriMidin-4-yl)aMino)piperidin-1-yl)-3-oxopropanenitrile](/CAS/GIF/1092578-48-7.gif) |
3-((3S,4R)-4-Methyl-3-(Methyl(7H-pyrrolo[2,3-d]pyriMidin-4-yl)aMino)piperidin-1-yl)-3-oxopropanenitrile |
1092578-48-7 |
C16H20N6O |
![グラニセトロン関連化合物C (N-[(1R,3R,5S)-9-アザビシクロ[3.3.1]ノン-3-イル]-1-メチル-1H-インダゾール-3-カルボキサミド塩酸塩)](/CAS/GIF/141136-01-8.gif) |
グラニセトロン関連化合物C (N-[(1R,3R,5S)-9-アザビシクロ[3.3.1]ノン-3-イル]-1-メチル-1H-インダゾール-3-カルボキサミド塩酸塩) |
141136-01-8 |
C17H22N4O.ClH |
 |
ラベプラゾールスルホン |
117976-47-3 |
C18H21N3O4S |
 |
Isavuconazole Impurity 16 |
|
|
 |
ClarithroMycin 9-OxiMe |
103450-87-9 |
C38H70N2O13 |
 |
Canagliflozin Impurity F |
|
|
 |
Oxacillin sodium EP impurity J |
|
|
 |
1-(5,6-dihydronaphthalen-1-yl)ethan-1-amine hydrochloride |
1824506-44-6 |
C12H15N |
 |
Trelagliptin IMpurity 32 |
|
|
 |
10-O-2,2-Dichloroethoxycarbonyl Docetaxe |
158810-73-2 |
C46H55Cl2NO16 |
 |
Edaravone Impurity |
|
|
 |
Ceftazidime Oxide Impurity |
1301254-48-7 |
C22H22N6O8S2 |
 |
Epinephrine Impurity 7 |
62322-82-1 |
C9H11NO3 |
 |
Tirofiban IMpurity (4,4'-Dipyridyl-1,5-Pentane) |
25382-33-6 |
C15H18N2 |
 |
(R)-Methyl 3-aMino-4-(2,4,5-trifluorophenyl) butanoate .(R)-2-hydroxy-2-phenylacetate |
1253055-94-5 |
C19H20F3NO5 |
 |
Ambrisentan Impurity 3 |
178306-49-5 |
C16H16O4 |
 |
Tofacitinib Impurity 92 |
|
|
![2,2'-((piperazine-1,4-disulfonyl)bis(2-ethoxy-5,1-phenylene))bis(5-methyl-7-propylimidazo[5,1-f][1,2,4]triazin-4(3H)-one)](/CAS/20200611/GIF/1255919-03-9.gif) |
2,2'-((piperazine-1,4-disulfonyl)bis(2-ethoxy-5,1-phenylene))bis(5-methyl-7-propylimidazo[5,1-f][1,2,4]triazin-4(3H)-one) |
1255919-03-9 |
C38H46N10O8S2 |
![(2S,5β)-6α-ブロモ-3,3-ジメチル-7-オキソ-4-チア-1-アザビシクロ[3.2.0]ヘプタン-2β-カルボン酸ナトリウム](/CAS/GIF/73335-78-1.gif) |
(2S,5β)-6α-ブロモ-3,3-ジメチル-7-オキソ-4-チア-1-アザビシクロ[3.2.0]ヘプタン-2β-カルボン酸ナトリウム |
73335-78-1 |
C8H9BrNNaO3S |
 |
Benzene, 1-(3-chloropropyl)-3-(trifluoroMethyl)- |
82258-76-2 |
C10H10ClF3 |
![(7R)-3-(ヒドロキシメチル)-7-[[(R)-5-アミノ-5-カルボキシ-1-オキソペンチル]アミノ]セファム-3-エン-4-カルボン酸](/CAS/20200611/GIF/1476-46-6.gif) |
(7R)-3-(ヒドロキシメチル)-7-[[(R)-5-アミノ-5-カルボキシ-1-オキソペンチル]アミノ]セファム-3-エン-4-カルボン酸 |
1476-46-6 |
C14H19N3O7S |
 |
Oseltamivir Impurity 12 |
|
|
 |
Olaparib Impurity 4 |
|
|
![5H-ジベンゾ[b,f]アゼピン-10,11-ジオン](/CAS/GIF/19579-83-0.gif) |
5H-ジベンゾ[b,f]アゼピン-10,11-ジオン |
19579-83-0 |
C14H9NO2 |
 |
Beclometasone Impurity U |
|
|
 |
Febuxostat Impurity 14 |
1335202-60-2 |
C15H16N2OS |
 |
Sunitinib Impurity 5 |
|
|
 |
Canagliflozin Impurity 8 |
|
|
 |
Sugammadex sodium Impurity 45 |
|
|
 |
Pregabalin Lactam (S)-Isomer Lactose Adduct |
466678-44-4 |
C20H35NO11 |
 |
Cyclopentolate Impurity |
36882-00-5 |
C12H17NO2 |
 |
Canagliflozin Impurity 33 |
|
|
 |
3-(ジメチルアミノ)-1-(2-チエニル)-1-プロパノール |
13636-02-7 |
C9H15NOS |
 |
4-メチルけい皮酸エチル |
24393-49-5 |
C12H14O2 |
 |
Atracurium Impurity 31 |
|
|
 |
4,5-ジヒドロ-Α-(ヒドロキシメチル)-Α,3-ジメチル-5-オキソ-1-フェニル-1H-ピラゾール-4-メタンスルホン酸 |
1242471-40-4 |
C13H16N2O5S |
 |
SofosBuvir impurity 62 |
|
|
 |
5-(2-アミノエチルチオメチル)-N,N-ジメチル-2-フランメタンアミン |
66356-53-4 |
C10H18N2OS |
![1H-Purine-2,6-dione,8-[2-(3,4-dihydroxyphenyl)ethenyl]-1,3-diethyl-3,7-dihydro-7-methyl-, (E)-(9CI)](/CAS/20180601/GIF/155272-03-0.gif) |
1H-Purine-2,6-dione,8-[2-(3,4-dihydroxyphenyl)ethenyl]-1,3-diethyl-3,7-dihydro-7-methyl-, (E)-(9CI) |
155272-03-0 |
C18H20N4O4 |
 |
MEGACELL™ ダルベッコ改変イーグル培地 |
|
|
 |
Febuxostat Impurity 53 |
|
|
 |
9-MethoxyMethyl Guanine |
1202645-50-8 |
C7H9N5O2 |
 |
Oseltamivir Impurity 47 |
|
|
 |
Zolmitriptan |
139264-24-7 |
C16H21N3O2 |
 |
Sugammadex sodium Org205485-1 Impurity |
|
|
 |
Losartan Impurity 7 |
358685-13-9 |
C33H24Br2N4 |
 |
2-イソプロペニル-6-イソプロピルフェノール |
74926-89-9 |
C12H16O |
 |
Tirofiban hydrochloride monohydrate Impurity 7 |
2250244-28-9 |
C13H19NO5S |
 |
Lenvatinib Impurity 25 |
|
|
 |
Rosuvastatin Impurity 39 |
|
|
 |
(E/Z)-FK-50626,28-アリリックエステル転位不純物 |
131944-48-4 |
C44H69NO12 |
 |
1-シクロプロピル-6,7-ジフルオロ-1,4-ジヒドロ-8-ヒドロキシ-4-オキソ-3-キノリンカルボン酸エチルエステル |
452092-31-8 |
C15H13F2NO4 |
 |
Vonoprazan Impurity E |
|
|
 |
Lincomycin sulfoxide Impurity D |
|
|
 |
Raltegravir USP RC E |
1193687-87-4 |
C20H22N6O5 |
 |
Piperacillin Sulfoxide |
67275-27-8 |
C23H27N5O8S |
 |
RocuroniuMbroMide iMpurity H |
|
|
 |
6,6'-oxybis(3-((4-oxo-3,4-dihydrophthalazin-1-yl)methyl)benzonitrile) |
|
|
 |
Olprinone Impurity A |
141354-29-2 |
C12H10N4O |
 |
1-((2R,3S,4R,5R)-3,4-dihydroxy-5-(hydroxyMethyl)-3-Methyltetrahydrofuran-2-yl)pyriMidine-2,4(1H,3H)-dione |
114262-49-6 |
C10H14N2O6 |
 |
Merariveron impurity C |
|
|
 |
SulbactaM IMpurity A |
|
|
 |
Canagliflozin open-ring impurity |
|
|
 |
2-(1-オキソプロピル)安息香酸 |
2360-45-4 |
C10H10O3 |
![ethyl 1-(4-chlorophenyl)-7-oxo-6-(4-(2-oxopiperidin-1-yl)phenyl)-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxylate](/CAS/20200119/GIF/2029205-62-5.gif) |
ethyl 1-(4-chlorophenyl)-7-oxo-6-(4-(2-oxopiperidin-1-yl)phenyl)-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxylate |
2029205-62-5 |
C26H25ClN4O4 |
 |
6,6'-oxybis(3-((4-oxo-3,4-dihydrophthalazin-1-yl)methyl)benzoic acid) |
|
|
 |
Canagliflozin Impurity 26 |
|
|
 |
Cefradine Impurity B |
|
|
 |
Ceftazidime Impurity A (EP) |
|
|
 |
Rizatriptan IMpurity B |
1016900-28-9 |
C13H15ClN5 |
 |
Pantoprazole Impurity 12 |
|
|
 |
ゲニステイン 7,4-di-O-β-D-グルコピラノシド |
36190-98-4 |
C27H30O15 |
 |
Dapoxetine impurity 57 |
|
|
 |
Peramivir Diastereomer Impurity 1 |
|
|